VEGF and bone cell signalling: An essential vessel for communication?

Cell Biochemistry and Function

Volumn 31, Issue 1, 2013, Pages 1-11

  Clarkin, Claire E ^a   Gerstenfeld, Louis C ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Bone; Endothelial cells; Osteoblasts; Osteoclasts; VEGF

Indexed keywords

ATORVASTATIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; CERIVASTATIN; ESTRADIOL; FIBROBLAST GROWTH FACTOR 2; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; NEUROPILIN 1; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PLACENTAL GROWTH FACTOR; PROSTAGLANDIN E1; PROSTAGLANDIN E2; SIMVASTATIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN ANTIBODY; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN E; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADIPOGENESIS; ANGIOGENESIS; ARTICLE; BLOOD VESSEL; BONE CELL; BONE DENSITY; BONE DEVELOPMENT; BONE METABOLISM; BONE REMODELING; CARTILAGE CELL; CELL COMMUNICATION; CELL FUNCTION; CELL HYPOXIA; CELL LINE; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MICROENVIRONMENT; MOLECULE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; RECEPTOR UPREGULATION; SHEAR STRESS; SIGNAL TRANSDUCTION;

AGE FACTORS; ANIMALS; BONE DEVELOPMENT; BONE REMODELING; BONE RESORPTION; CELL HYPOXIA; CELLULAR MICROENVIRONMENT; ENDOTHELIUM, VASCULAR; ESTROGENS; FRACTURE HEALING; HORMONES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; PARACRINE COMMUNICATION; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84872410777     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2911     Document Type: Article

References (111)

1. Trueta J, Buhr AJ. The vascular contribution to osteogenesis. V. The vasculature supplying the epiphysial cartilage in rachitic rats. J Bone Joint Surg Br 1963; 45: 572-81.
2. Trueta J, Little K. The vascular contribution to osteogenesis. II. Studies with the electron microscope. J Bone Joint Surg Br 1960; 42: 367-76.
3. Hauge EM, Qvesel D, Eriksen EF, et al. Cancellous Bone Remodelling Occurs in Specialized Compartments Lined by Cells Expressing Osteoblastic Markers. J Bone Miner Res 2001; 16: 1575-82.
4. Carano RA, Filvaroff EH. Angiogenesis and bone repair. Drug Discov Today 2003; 8: 980-9.
5. Sacchetti B, Funari A, Michienzi S, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007; 131: 324-36.
6. Roche B, David V, Vanden-Bossche A, et al. Structure and quantification of microvascularisation within mouse long bones: what and how should we measure? Bone 2012; 50: 390-9.
7. Dilling CF, Wada AM, Lazard ZW, et al. Vessel Formation is Induced Prior to the Appearance of Cartilage in BMP2-Mediated Heterotopic Ossification. J Bone Miner Res 2010; 25: 1147-56.
8. Eshkar-Oren I, Viukov SV, Salameh S, et al. The forming limb skeleton serves as a signaling center for limb vasculature patterning via regulation of Vegf. Development 2009; 136: 1263-72.
9. Brandi ML, Collin-Osdoby P. Vascular Biology and the Skeleton. J Bone Miner Res 2006; 21: 183-92.
10. Maes C, Kobayashi T, Selig MK, et al. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell 2010; 19: 329-44.
11. Gerber HP, Vu TH, Ryan AM, et al. VEGF couples hypertrophic cartilage remodelling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999; 5: 623-8.
12. Brown LF, Yeo KT, Berse B, et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992; 176: 1375-9.
13. Frank S, Hübner G, Breier G, et al. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 1995; 26(270): 12607-13.
14. Maharaj AS, D'Amore PA. Roles for VEGF in the adult. Microvasc Res 2007; 74: 100-13.
15. Burkhardt R, Kettner G, Böhm W, et al. Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study. Bone 1987; 8: 157-64.
16. Ding W-G, Wei Z-X, Liu J-B. Reduced local blood supply to the tibial metaphysis is associated with ovariectomy-induced osteoporosis in mice. Connect Tiss Res 2011; 52: 25-29.
17. Street J, Bao M, de Guzman L, et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 2002; 99: 9656-61.
18. Fang TD, Salim A, Xia W. Angiogenesis is required for successful bone induction during distraction osteogenesis. J Bone Miner Res 2005; 20: 1114-24.
19. Peng H, Usas A, Olshanski A. VEGF improves, whereas sFlt-1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 2005; 20: 2017-27.
20. Dickson KF, Katzman S, Paiement G. The importance of the blood supply in the healing of tibial fractures. Contemp Orthop 1995; 30: 489-93.
21. Park S, Han S, Lee T. Algorithm for recipient vessels selection in free transfer to the lower extremity. Plast Reconstr Surg 1999; 103: 1937-48.
22. Lu C, Miclau T, Hu D, et al. Ischemia leads to delayed union during fracture healing: a mouse model. J Orthop Res 2007; 25: 51-61.
23. Lu C, Hansen E, Sapozhnikova A, et al. Effect of age on vascularization during fracture repair. J Orthop Res 2008; 26: 1384-9.
24. D'Amore PA. Vascular endothelial cell growth factor-A: not just for endothelial cells anymore. Am J Pathol 2007; 171: 14-8.
25. Cross MJ, Dixelius J, Matsumoto T, et al. VEGF-receptor signal transduction. Trends Biochem Sci 2003; 28: 488-94.
26. Ferrara N, Gerber H, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-76.
27. Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999; 13: 9-22.
28. Houck KA, Leung DW, Rowland AM, et al. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992; 267: 26031-7.
29. Koch S, Tugues S, Li X, et al. Signal transduction by vascular endothelial growth factor receptors. Biochem J 2011; 437: 169-83.
30. Mayr-wohlfart U, Waltenberger J, Hausser H, et al. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 2002; 30: 472-7.
31. Ishida A, Murray J, Saito Y, et al. Expression of Vascular Endothelial Growth Factor Receptors in Smooth Muscle Cells. J Cell Physiol 2001; 188: 359-368.
32. Wu W, Shu X, Hovsepyan H, et al. VEGF receptor expression and signaling in human bladder tumors. Oncogene 2003; 22: 3361-3370.
33. Wang DS, Yamazaki K, Nohtomi K, et al. Increase of vascular endothelial growth factor mRNA expression by 1, 25-dihydroxyvitamin D3 in human osteoblast-like cells. J Bone Miner Res 1996; 11: 472-9.
34. Steinbrech DS, Mehrara BJ, Saadeh PB, et al. VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism. Am J Physiol Cell Physiol 2000; 278: C853-60.
35. Spector JA, Mehrara BJ, Greenwald JA, et al. Osteoblast expression of vascular endothelial growth factor is modulated by the extracellular microenvironment. Am J Physiol Cell Physiol 2001; 280: C72-80.
36. Wang Y, Wan C, Deng L, et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 2007; 117: 1616-26.
37. Wan C, Gilbert SR, Wang Y, et al. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci USA 2008; 105: 686-9.
38. Weinstein RS, Wan C, Liu Q, et al. Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell 2010; 9: 147-62.
39. Rubin C, Turner AS, Bain S, et al. Anabolism: Low mechanical signals strengthen long bones. Nature 2001; 412: 603-4.
40. Jaasma MJ, Jackson WM, Tang RY, et al. Adaptation of cellular mechanical behavior to mechanical loading for osteoblastic cells. J Biomech 2007; 40: 1938-45.
41. Schriefer JL, Warden SJ, Saxon LK, et al. Cellular accommodation and the response of bone to mechanical loading. J Biomech 2005; 38: 1838-45.
42. Hoberg M, Gratz HH, Noll M, et al. Mechanosensitivity of human osteosarcoma cells and phospholipase C [beta]2 expression. Biochem Biophys Res Commun 2005; 333: 142-9.
43. Yao Z, Lafage-Proust MH, Plouët J, et al. Increase of Both Angiogenesis and Bone Mass in Response to Exercise Depends on VEGF. J Bone Miner Res 2004; 19: 1471-80.
44. Wohl GR, Towler DA, Silva M. Stress fracture healing: fatigue loading of the rat ulna induces upregulation in expression of osteogenic and angiogenic genes that mimic the intramembranous portion of fracture repair. Bone 2009; 44: 320-30.
45. Pacicca DM, Patel N, Lee C, et al. Expression of Angiogenic Factors During Distraction Osteogenesis. Bone 2003; 33: 889-98.
46. Carvalho RS, Einhorn T, Lehman W, et al. The role of angiogenesis in a murine tibial model of distraction osteogenesis. Bone 2004; 34: 849-61.
47. Quinn TP, Schlueter M, Soifer SJ, Gutierrez JA. Cyclic mechanical stretch induces VEGF and FGF-2 expression in pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2002; 282: L897-903.
48. Mata-Greenwood E, Grobe A, Kumar S, Noskina Y, Black SM. Cyclic stretch increases VEGF expression in pulmonary arterial smooth muscle cells via TGF-beta1 and reactive oxygen species: a requirement for NAD(P)H oxidase. Am J Physiol Lung Cell Mol Physiol 2005; 289: L288-9.
49. Gruden G, Thomas S, Burt D, et al. Mechanical stretch induces vascular permeability factor in human mesangial cells: mechanisms of signal transduction. Proc Natl Acad Sci USA 1997; 94: 12112-6.
50. Seko Y, Seko Y, Fujikura H, Pang J, Tokoro T, Shimokawa H. Induction of vascular endothelial growth factor after application of mechanical stress to retinal pigment epithelium of the rat in vitro. Invest Ophthalmol Vis Sci 1999; 40: 3287-91.
51. Muratore CS, Nguyen HT, Ziegler MM, Wilson JM. Stretch-induced upregulation of VEGF gene expression in murine pulmonary culture: a role for angiogenesis in lung development. J Pediatr Surg 2000; 35: 906-12 discussion 912-3.
52. Suzuma I, Suzuma K, Ueki K, et al. Stretch-induced retinal vascular endothelial growth factor expression is mediated by phosphatidylinositol 3-kinase and protein kinase C (PKC)-zeta but not by stretch-induced ERK1/2, Akt, Ras, or classical/novel PKC pathways. J Biol Chem 2002; 11(277): 1047-57.
53. Pufe T, Claassen H, Scholz-Ahrens K, et al. Influence of Estradiol on Vascular Endothelial Growth Factor Expression in Bone: A Study in Göttingen Miniature Pigs and Human Osteoblasts. Calcif Tiss Intern 2007; 80: 184-91.
54. Schlaeppi J-M, Gutzwiller S, Finkenzeller G, et al. 1, 25-Dihydroxyvitamin D3 induces the expression of vascular endothelial growth factor in osteoblastic cells. Endocrinol Res 1997; 23: 213-29.
55. Prisby R, Guignandon A, Vanden-Bossche A, et al. Intermittent PTH(1-84) is osteoanabolic but not osteoangiogenic and relocates bone marrow blood vessels closer to bone-forming sites. J Bone Miner Res 2011; 26: 2583-96.
56. Harada S, Nagy JA, Sullivan KA, et al. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest 1994; 93: 2490-6.
57. Clarkin CE, Emery RJ, Pitsillides AA, et al. Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells. J Cell Physiol 2008; 214: 537-44.
58. Goad D, Rubin J, Wang H, et al. Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I. Endocrinology 1996; 137: 2262-8.
59. Saadeh PB, Mehrara BJ, Steinbrech DS, et al. Mechanisms of fibroblast growth factor-2 modulation of vascular endothelial growth factor expression by osteoblastic cells. Endocrinology 2000; 141: 2075-83.
60. Deckers MML, Karperien M, van der Bent C, et al. Expression of Vascular Endothelial Growth Factors and Their Receptors during Osteoblast Differentiation. Endocrinology 2000; 141: 1667-74.
61. Yeh L-CC, Lee JC. Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells. Mol Cell Endocrin 1999; 153: 113-24.
62. Furumatsu T, Shen ZN, Kawai A, et al. Vascular Endothelial Growth Factor Principally Acts as the Main Angiogenic Factor in the Early Stage of Human Osteoblastogenesis. J Biochem 2003; 133: 633-9.
63. Kuno M, Takai S, Matsushima-Nishiwaki R, et al. Rho-kinase inhibitors decrease TGF-[beta]-stimulated VEGF synthesis through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts. Biochem Pharma 2009; 77: 196-203.
64. Chua CC, Hamdy RC, Chua BHL. Mechanism of transforming growth factor-[beta]1-induced expression of vascular endothelial growth factor in murine osteoblastic MC3T3-E1 cells. Biochim Biophys Acta (BBA)-Mol Cell Res 2000; 1497: 69-76.
65. Kanno Y, Tokuda H, Nakajima K, et al. Involvement of SAPK/JNK in prostaglandin E1-induced VEGF synthesis in osteoblast-like cells. Mol Cell Endocrinol 2004; 220: 89-95.
66. Takai S, Tokuda H, Hanai Y, et al. Negative Regulation by p70 S6 Kinase of FGF-2-Stimulated VEGF Release Through Stress-Activated Protein Kinase/c-Jun N-Terminal Kinase in Osteoblasts. J Bone Miner Res 2007; 22: 337-46.
67. Natsume H, Tokuda H, Adachi S, et al. Rho-kinase limits FGF-2-stimulated VEGF release in osteoblasts. Bone 2010; 46: 1068-74 87.
68. Tang W, Yang F, Li Y, et al. Transcriptional regulation of vascular endothelial growth factor (VEGF) by osteoblast-specific transcription factor osterix (Osx) in osteoblasts. J Biol Chem 2012; 287: 1671-1678.
69. Maharaj AS, Saint-Geniez M, Maldonado AE, et al. Vascular endothelial growth factor localization in the adult. Am J Pathol 2006; 168(2): 639-48.
70. Saint-Geniez M, Maharaj AS, Walshe TE, et al. Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors. PLoS One 2008; 3: e3554.
71. Couffinhal T, Kearney M, Witzenbichler B, et al. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol 1997; 150(5): 1673-85.
72. Hamlat A, Adn M, Pasqualini E, et al. Pathophysiology of capillary haemangioma growth after birth. Med Hypotheses 2005; 64(6): 1093-6.
73. Tang N, Wang L, Esko J, et al. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 2004; 6(5): 485-95.
74. Namiki A, Brogi E, Kearney M, et al. Hypoxia Induces Vascular Endothelial Growth Factor in Cultured Human Endothelial Cells. J Biol Chem 1995; 270: 31189-95.
75. Lee S, Chen TT, Barber CL, et al. Autocrine VEGF Signaling Is Required for Vascular Homeostasis. Cell 2007; 130: 691-703.
76. Kuhn A, Brachtendorf G, Kurth F, et al. Expression of endomucin, a novel endothelial sialomucin, in normal and diseased human skin. J Invest Dermatol 2002; 119: 1388-93.
77. dela Paz NG, D'Amore PA. Arterial versus venous endothelial cells. Cell Tissue Res 2009; 335: 5-16.
78. Samulowitz U, Kuhn A, Brachtendorf G, et al. Human endomucin: distribution pattern, expression on high endothelial venules, and decoration with the MECA-79 epitope. Am J Pathol 2002; 160: 1669-81.
79. Trebec-Reynolds DP, Voronov I, Heersche JN, et al. VEGF-A expression in osteoclasts is regulated by NF-κB induction of HIF-1α. J Cell Biochem 2010; 110: 343-51.
80. Utting JC, Robins SP, Brandao-Burch A, et al. Hypoxia inhibits the growth, differentiation and bone-forming capacity of rat osteoblasts. Exp Cell Res 2006; 312: 1693-702.
81. Engsig MT, Chen QJ, Vu TH. The Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones. J Cell Biol 2000; 151(4): 879-889.
82. Cackowski F, Anderson JL, Patrene KD. Osteoclasts are important for bone angiogenesis. Blood 2010; 115: 140-149.
83. Harper J, Gerstenfeld LC, Klagsbrun M. Neuropilin-1 expression in osteogenic cells: down-regulation during differentiation of osteoblasts into osteocytes. J Cell Biochem 2001; 81: 82-92.
84. Matsubara H, Hogan DE, Morgan EF, et al. Vascular Tissues Are a Primary Source of BMP2 Expression during Bone Formation Induced by Distraction Osteogenesis. Bone 2012; 51(3): 535-45.
85. Street J, Lenehan B. Vascular endothelial growth factor regulates osteoblast survival-evidence for an autocrine feedback mechanism. J Orthop Surg Res 2009; 4: 19.
86. Fitch J, Birkhead J, Nugent E, et al. Vascular Endothelial Cells Produce Factors that Promote Osteogenic Differentiation of MSCs but Inhibit Mineral Deposition and Terminal Osteocyte Differentiation ASMBR Annual Meeting, 2011.
87. Athanasopoulos AN, Schneider D, Keiper T, et al. Vascular Endothelial Growth Factor (VEGF)-induced Up-regulation of CCN1 in Osteoblasts Mediates Proangiogenic Activities in Endothelial Cells and Promotes Fracture Healing. J Biol Chem 2007; 282: 26746-53.
88. Zelzer E, McLean W, Ng Y-S, et al. Skeletal defects in VEGF120/120 mice reveal multiple roles for VEGF in skeletogenesis. Development 2002; 129: 1893-904.
89. Gao J, Yang T, Han J, et al. MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow. J Cell Biochem 2011; 112: 1844-56.
90. Murakami M, Nguyen LT, Hatanaka K, et al. FGF-dependent regulation of VEGF receptor 2 expression in mice. J Clin Invest 2011; 121: 2668-78.
91. Thi MM, Suadicani SO, Spray DC. Fluid flow-induced soluble vascular endothelial growth factor isoforms regulate actin adaptation in osteoblasts. J Biol Chem 2010; 285: 30931-41.
92. Nakai T, Yoshimura Y, Deyama Y, et al. Mechanical stress up-regulates RANKL expression via the VEGF autocrine pathway in osteoblastic MC3T3-E1 cells. Mol Med Rep 2009; 2: 229-34.
93. Cheung W, Liu C, Tonelli-Zasarsky RM, et al. Osteocyte apoptosis is mechanically regulated and induces angiogenesis in vitro. J Orthop Res 2011; 29: 523-30.
94. Clarkin CE, Garonna E, Pitsillides AA, et al. Heterotypic contact reveals a COX-2-mediated suppression of osteoblast differentiation by endothelial cells: A negative modulatory role for prostanoids in VEGF-mediated cell: cell communication? Exp Cell Res 2008; 314: 3152-61.
95. Liu Y, Berendsen AD, Jia S, et al. Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation. J Clin Invest 2012; 122: 3101-3113.
96. Gerber HP, Malik AK, Solar GP, et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 2002; 417: 954-8.
97. Formigli L, Zecchi Orlandini S, Benvenuti S, et al. In vitro structural and functional relationships between preosteoclastic and bone endothelial cells: A juxtacrine model for migration and adhesion of osteoclast precursors. J Cell Physiol 1995; 162: 199-212.
98. Collin-Osdoby P, Rothe L, Anderson F, et al. Receptor activator of NF-kB ligand and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem 2001; 276: 20659-72.
99. McGowan N, Walker E, MacPherson H, et al. Cytokine-activated endothelium recruits osteoclast precursors. Endocrinology 2001; 142: 1678-81.
100. Blair L, Rothe L, Osdoby P, et al. Activation of human microvascular endothelial cells by IL-1 or TNF enhances transendothelial migration and chemokine (SDF-1) recruitment of precursors from human peripheral blood that develop into osteoclasts. J Bone Miner Res 2003; 18: S326.
101. Collin-Osdoby P, Rothe L, Bekker S, et al. Decreased nitric oxide levels stimulate osteoclastogenesis and bone resorption both in vitro and in vivo on the chick chorioallantoic membrane in association with neoangiogenesis. J Bone Miner Res 2000; 15: 474-88.
102. Winding B, Misander H, Sveigaard C, et al. Human breast cancer cells induced angiogenesis, recruitment, and activation of osteoclasts in osteolytic metastasis. J Cancer Res Clin Oncol 2000; 126: 631-40.
103. Asou Y, Rittling S, Yoshitake H, et al. Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption. Endocrinology 2001; 142: 1325-32.
104. Yang Q, McHugh KP, Patntirapong S, et al. VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and [beta]3-integrin. Matrix Biol 2008; 27: 589-99.
105. Zhang Q, Guo R, Lu Y, et al. VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism. J Biol Chem 2008; 283: 13491-9.
106. Niida S, Kondo T, Hiratsuka S, et al. VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice. Proc Nat Acad Sci USA 2005; 102: 14016-21.
107. Min J-K, Kim Y-M, Kim Y-M, et al. Vascular Endothelial Growth Factor Up-regulates Expression of Receptor Activator of NF-κB (RANK) in Endothelial Cells. J Biol Chem 2003; 278: 39548-57.
108. Fan W, Bouwense SA, Crawford R, et al. Structural and cellular features in metaphyseal and diaphyseal periosteum of osteoporotic rats. J Mol Histol 2010; 41: 51-60.
109. Mundy G, Garrett R, Harris S, et al. Stimulation of Bone Formation in Vitro and in Rodents by Statins. Science 1999; 286: 1946-9.
110. Simons M. An inside view: VEGF receptor trafficking and signalling. Physiology 2012; 27: 213-22.
111. Medici D, Shore EM, Lounev VY, et al. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 2010; 16: 1400-6.